Adding cagrilintide to tirzepatide Theoretical protocol (not clinically studied): If on tirzepatide 10-15mg: Stable on tirzepatide for 4+ weeks Continue tirzepatide at current dose Add cagrilintide 0.6mg weekly Standard cagrilintide titration to 2.4mg Rationale: Tirzepatide is dual GIP/GLP-1 (very powerful alone) Adding amylin pathway could theoretically enhance No clinical data on this combination Uncertain if additional benefit over tirzepatide alone Concerns: GI side effects may be severe (both slow gastric emptying) Tirzepatide already produces 15-22% weight loss alone Unclear if cagrilintide adds meaningful benefit Expensive combination Verdict: Wait for clinical data
The two can potentially be combined for complementary effects -- carnosine for damage prevention and epitalon for telomere maintenance
COA & Testing (30%) Third-party labs (Janoshik, MZ Biolabs, Colmaric) Recent (within 6 months) Verifiable task number Mass spec confirming 850 Da Reputation (30%) Community feedback, shipping reliability, customer service, multi-year track record
Importantly, amylin-responsive neurons in the AP do not express co-receptors for GLP-1 and GLP-15, suggesting different primary targets of these peptides
This would suggest that epitalon can be safely used in healthy individuals to maintain telomeres and thereby influence the aging process
